Kyle Munz

home / authors / kyle-munz

Articles

Снежана Кудрявцева-stock.adobe.com

Analysis: Consumer Out-of-Pocket Drug Costs Rise Faster than Insurer Costs

Kyle Munz
September 4th 2024

The growth of out-of-pocket and insurer/negotiated prices paralleled one another until 2016 when negotiated and insurer prices began declining

Read More

© ag visuell - stock.adobe.com

Relationship Discovered Between Sleep Characteristics and Gut Microbiota

Kyle Munz
February 21st 2024

New insight could change the way physicians treat disorders like insomnia.

Read More

Antinucleocapsid Antibody Detection Can Help Diagnose Postacute Sequelae of SARS-CoV-2, Improve Treatment Access

Antinucleocapsid Antibody Detection Can Help Diagnose Postacute Sequelae of SARS-CoV-2, Improve Treatment Access

Kyle Munz
September 18th 2023

Researchers investigated methods for measuring prior exposure in patients with suspected, undocumented COVID-19 infection to give better access to care and counsel.

Read More

Latest Updated Articles

Gaps in Diabetes Patient Education and Rising Healthcare Costs
Published: February 25th 2025 | Updated: February 28th 2025
Gaps in Diabetes Patient Education and Rising Healthcare Costs
black and white image of solders in jungle setting | ©daniel stock.adobe.com
Published: February 16th 2025 | Updated: February 19th 2025
Many Aging Vietnam War Vets Are Still Battling PTSD, Along With Chronic Illnesses, That Combat Exposure May Make More Likely, New Research Finds
food in heart shape with a stethoscope | image credit: ©udra11
Published: February 5th 2025 | Updated: February 7th 2025
A Key Ingredient to ‘Food is Medicine’: Standardization
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Published: January 30th 2025 | Updated: January 31st 2025
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Navigating Healthcare's Future: An Insider's View on Network Strategy, Employer Innovation and Policy Challenges
Published: June 27th 2025 | Updated: June 30th 2025
Navigating Healthcare's Future: An Insider's View on Network Strategy, Employer Innovation and Policy Challenges
FDA Approves Dupixent as First Targeted Treatment for Bullous Pemphigoid in Adults
Published: June 20th 2025 | Updated: June 30th 2025
FDA Approves Dupixent as First Targeted Treatment for Bullous Pemphigoid in Adults
© 2025 MJH Life Sciences

All rights reserved.